Hypothyroidism
📧 Sign up to get email alerts when something new happens for Hypothyroidism.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2009-03-26FDA Approved: EUTHYROX — Supplemental Application (Provell Pharmaceuticals, LLC)
FDA approved a supplemental application for EUTHYROX (levothyroxine sodium) from Provell Pharmaceuticals, LLC, indicating a modification to …
-
FDA approval · 2009-03-20FDA Approved: LIOTHYRONINE SODIUM — Original Application (Dr. Reddy's Labratories Inc.)
FDA approved an original Abbreviated New Drug Application for Liothyronine sodium from Dr. Reddy's Labratories Inc., making a generic thyroi…
-
FDA approval · 2008-10-30FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for levothyroxine sodium from Mylan Pharmaceuticals Inc., granting regulatory approval for this gene…
-
CLINICAL_TRIALS trial_result · 2008-09-11Clinical Trial Update: TSH Receptor Mutations Among a Consanguineous Community
Completed clinical trial from HaEmek Medical Center in Israel investigating TSH receptor mutations in a consanguineous community and their l…
-
CLINICAL_TRIALS trial_result · 2008-07-15Clinical Trial Update: Combined Therapy With L-Thyroxine and L-Triiodothyronine Compared to L-Thyroxine Alone [NA]
This document reports on a completed clinical trial comparing combination therapy with levothyroxine and liothyronine to levothyroxine alone…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2008-07-14FDA Approved: SYNTHROID — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for Synthroid (levothyroxine sodium) submitted by AbbVie Inc. The approval relates to changes in…
-
FDA approval · 2008-07-08FDA Approved: LEVOXYL — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for Levoxyl (levothyroxine sodium) submitted by Pfizer Laboratories Div Pfizer Inc, resulting in…
-
FDA approval · 2008-06-10FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Lannett Company, Inc)
The FDA approved a supplemental application for levothyroxine sodium submitted by Lannett Company, Inc., authorizing continued marketing of …
-
CLINICAL_TRIALS trial_result · 2008-06-09Clinical Trial Update: Phase 4 Study in Secondary Hypothyroidism: Body Weight Adapted Thyroxin Treatment and Triiodothyronine Supplementation [Phase 4]
Phase 4 clinical trial update evaluating body weight–adjusted thyroxine therapy with triiodothyronine supplementation in secondary hypothyro…
-
FDA approval · 2008-04-20FDA Approved: SYNTHROID — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for Synthroid (levothyroxine sodium) from AbbVie, indicating an update to the product’s labeling…
-
CLINICAL_TRIALS research · 2008-03-04Clinical Trial Update: Study of Radioiodine (131-I) Uptake Following Administration of Thyrogen and Hypothyroid States During Thyroid Hormone Withdrawal. [Phase 4]
Phase 4 trial update investigating uptake of radioactive iodine (I-131) after Thyrogen administration in hypothyroid states during thyroid h…
-
CLINICAL_TRIALS trial_result · 2008-02-12Clinical Trial Update: Metabolic Changes in Hypothyroid Patients [NA]
A completed clinical trial update investigating metabolic changes in patients with hypothyroidism.
-
FDA approval · 2008-02-08FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approved a supplemental application for Levothyroxine Sodium (Amneal Pharmaceuticals NY LLC), approving changes to the existing NDA for …
-
FDA approval · 2008-01-01FDA Approved: TIROSINT — Supplemental Application (IBSA Pharma Inc.)
FDA approved a supplemental application for TIROSINT (levothyroxine sodium) from IBSA Pharma Inc., updating labeling as part of the suppleme…
-
FDA approval · 2007-12-17FDA Approved: TIROSINT — Supplemental Application (IBSA Pharma Inc.)
FDA approved a supplemental application for TIROSINT (levothyroxine sodium) submitted by IBSA Pharma Inc., expanding the regulatory approval…
-
CLINICAL_TRIALS trial_result · 2007-09-19Clinical Trial Update: Effect of T4-T3 Combination Therapy Versus T4 Monotherapy in Patients With Hypothyroidism [Phase 4]
A Phase 4 trial comparing levothyroxine (T4) plus liothyronine (T3) versus levothyroxine alone in hypothyroidism has been completed, with as…
-
FDA approval · 2006-12-21FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Mylan Pharmaceuticals' levothyroxine sodium product, indicating approval of changes to this gene…
-
FDA approval · 2006-12-15FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA granted approval of a supplemental application for levothyroxine sodium by Mylan Pharmaceuticals Inc., updating the drug’s labeling …
-
FDA approval · 2006-12-13FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Levothyroxine Sodium from Mylan Pharmaceuticals Inc. (ANDA 076187).
-
FDA approval · 2006-10-13FDA Approved: TIROSINT — Original Application (IBSA Pharma Inc.)
FDA approved TIROSINT (levothyroxine sodium) from IBSA Pharma Inc. as an Original Application (NDA021924) for replacement therapy in thyroid…